{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-002954","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2022-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.478785+00:00","generated_at":"2026-06-27T09:22:24.842234+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"National Research Q4 revenue +10% to $38.3M, EPS $0.38; FY revenue +11% to $148.0M","bullets":["Q4 2021 revenue $38.3M (+10% YoY); operating income $12.9M (+26%); diluted EPS $0.38 vs $0.32.","Full-year 2021 revenue $148.0M (+11%); operating income $50.3M (+18%); diluted EPS $1.46 vs $1.45.","Cash flow from operations $46.3M (up 14%); net cash position $27.8M, up from $4.1M at year-end 2020.","Launched Health's Human Understanding Program to personalize patient care at scale.","Continued quarterly dividend and share repurchases funded by strong cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-002954","json":"https://secwatch.observer/filing/0001437749-22-002954.json","markdown":"https://secwatch.observer/filing/0001437749-22-002954.md","text":"https://secwatch.observer/filing/0001437749-22-002954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/0001437749-22-002954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774922002954/nrc20220209_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:22:24.842234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}